GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
4,260
Funds Holding Change
-19
Funds Holding Growth
-0.4%
Value
$894B
Holding in Top 10
754
Top 10 Change
+230
Top 10 Growth
+44%
Value Growth
+1%
New
152
Increased
1,817
Reduced
1,973
Closed
114
Capital Inflow
$37.3B
Capital Outflow
$25.1B
Net Capital Flow
+$12.2B
Capital Flow Change
+$14.6B
Calls
$9.58B
Puts
$10.2B
Net Calls
-$643M
Put/Call Ratio
1.07